BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 33270474)

  • 1. Vaccine safety - is the SARS-CoV-2 vaccine any different?
    Tau N; Yahav D; Shepshelovich D
    Hum Vaccin Immunother; 2021 May; 17(5):1322-1325. PubMed ID: 33270474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.
    Kesselheim AS; Darrow JJ; Kulldorff M; Brown BL; Mitra-Majumdar M; Lee CC; Moneer O; Avorn J
    Health Aff (Millwood); 2021 Jan; 40(1):25-32. PubMed ID: 33211535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 interventions in children: a balancing act.
    Emonts M
    Arch Dis Child; 2022 Mar; 107(3):e12. PubMed ID: 34674993
    [No Abstract]   [Full Text] [Related]  

  • 6. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA authorizes first single-shot COVID-19 vaccine.
    Mullard A
    Nat Rev Drug Discov; 2021 Apr; 20(4):251. PubMed ID: 33707753
    [No Abstract]   [Full Text] [Related]  

  • 8. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.
    Mallapaty S; Callaway E
    Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708
    [No Abstract]   [Full Text] [Related]  

  • 9. Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.
    MacPherson A; Hutchinson N; Schneider O; Oliviero E; Feldhake E; Ouimet C; Sheng J; Awan F; Wang C; Papenburg J; Basta NE; Kimmelman J
    Ann Intern Med; 2021 Mar; 174(3):326-334. PubMed ID: 33226855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Dal-Ré R; Caplan AL; Gluud C; Porcher R
    Ann Intern Med; 2021 Feb; 174(2):258-260. PubMed ID: 33216636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The race to make a COVID-19 vaccine.
    Boseley S
    Lancet; 2021 Sep; 398(10303):832-833. PubMed ID: 34481566
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of approved COVID-19 vaccines.
    Jamkhande A; Khairnar MR; Gavali N; Patil Y; Kapare SS; Bhosale KP
    Rocz Panstw Zakl Hig; 2021; 72(3):245-252. PubMed ID: 34553878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2020 race towards SARS-CoV-2 specific vaccines.
    Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
    Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA authorizes Moderna COVID-19 vaccine.
    Med Lett Drugs Ther; 2021 Jan; 63(1616):9-10. PubMed ID: 33512345
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-vaccine results are on the way - and scientists' concerns are growing.
    Mallapaty S; Ledford H
    Nature; 2020 Oct; 586(7827):16-17. PubMed ID: 32978611
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
    Connors M; Graham BS; Lane HC; Fauci AS
    Ann Intern Med; 2021 May; 174(5):687-690. PubMed ID: 33460347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted.
    Med Lett Drugs Ther; 2021 May; 63(1624):e1. PubMed ID: 33976095
    [No Abstract]   [Full Text] [Related]  

  • 18. Vaccines against COVID-19: Priority to mRNA-Based Formulations.
    Pascolo S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the Safety of COVID-19 Vaccines: A Primer.
    Petousis-Harris H
    Drug Saf; 2020 Dec; 43(12):1205-1210. PubMed ID: 32997318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Answering Key Questions About COVID-19 Vaccines.
    Goodman JL; Grabenstein JD; Braun MM
    JAMA; 2020 Nov; 324(20):2027-2028. PubMed ID: 33064145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 48.